Urinary cotinine and exposure to passive smoke in children and adolescents in Germany - Human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V).


Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
01 01 2023
Historique:
received: 16 06 2022
revised: 05 09 2022
accepted: 07 09 2022
pubmed: 14 9 2022
medline: 30 11 2022
entrez: 13 9 2022
Statut: ppublish

Résumé

Passive smoking is a preventable and significant cause of many serious health problems, with children being particularly at risk. In the fifth German Environmental Survey (GerES V), conducted from 2014 to 2017, information reflecting the extent of passive smoke exposure in children and adolescents was collected by interview-based questionnaires and human biomonitoring (HBM) analyses of cotinine in urine from 2260 participants, aged 3-17 years. Based on these population-representative data, we describe current passive smoke exposure stratified by different subgroups and identify specific exposure determinants using multivariate logistic regression. The questionnaire data revealed that 42% of children and adolescents lived with at least one smoker in the household. Quantifiable concentrations of cotinine could be detected in 56% of the participants. The overall median concentration of cotinine was 0.2 μg/L, with children and adolescents of low socioeconomic status found to be a group particularly affected by passive smoke with higher cotinine concentrations (median = 1.2 μg/L). In the multiple analysis, the most significant predictor of cotinine levels derived from the questionnaire was passive smoking at home (odds ratio (OR) 13.07 [95CI: 4.65, 36.70]). However, parental smoking and passive smoking among friends and relatives could also be identified as independent factors influencing elevated cotinine levels. The comparison between the previous cycle GerES IV (2003-2006) on 3-14-year-olds and GerES V shows that tobacco smoke exposure of children decreased significantly. This decrease is likely an effect of extensive non-smoker protection laws being enforced 2007-2008 on federal and state level. This is reflected by a halving of urinary cotinine concentrations. Nevertheless, our results indicate that passive smoke is still a relevant source of harmful pollutants for many children and adolescents in Germany, and thus support the need for further efforts to reduce passive smoke exposure, especially in the private environment.

Identifiants

pubmed: 36100102
pii: S0013-9351(22)01647-4
doi: 10.1016/j.envres.2022.114320
pii:
doi:

Substances chimiques

Cotinine K5161X06LL
Tobacco Smoke Pollution 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114320

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Domenica Hahn (D)

German Environment Agency (UBA), Berlin/Dessau-Roßlau, Germany. Electronic address: Domenica.Hahn@uba.de.

Maria Schmied-Tobies (M)

German Environment Agency (UBA), Berlin/Dessau-Roßlau, Germany.

Enrico Rucic (E)

German Environment Agency (UBA), Berlin/Dessau-Roßlau, Germany.

Nikola Pluym (N)

ABF Analytisch-Biologisches Forschungslabor GmbH, Planegg, Germany.

Max Scherer (M)

ABF Analytisch-Biologisches Forschungslabor GmbH, Planegg, Germany.

Malgorzata Debiak (M)

German Environment Agency (UBA), Berlin/Dessau-Roßlau, Germany.

Aline Murawski (A)

German Environment Agency (UBA), Berlin/Dessau-Roßlau, Germany. Electronic address: aline.murawski@uba.de.

Marike Kolossa-Gehring (M)

German Environment Agency (UBA), Berlin/Dessau-Roßlau, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH